A detailed history of Valmark Advisers, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Valmark Advisers, Inc. holds 1,296 shares of TMO stock, worth $679,168. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,296
Previous 1,117 16.03%
Holding current value
$679,168
Previous $617,000 29.82%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$531.86 - $624.21 $95,202 - $111,733
179 Added 16.03%
1,296 $801,000
Q2 2024

Jul 31, 2024

BUY
$541.52 - $599.02 $223,647 - $247,395
413 Added 58.66%
1,117 $617,000
Q1 2024

May 03, 2024

BUY
$528.82 - $599.43 $55,526 - $62,940
105 Added 17.53%
704 $409,000
Q4 2023

Feb 02, 2024

BUY
$431.41 - $532.94 $7,333 - $9,059
17 Added 2.92%
599 $317,000
Q3 2023

Nov 07, 2023

SELL
$498.29 - $574.41 $3,986 - $4,595
-8 Reduced 1.36%
582 $294,000
Q2 2023

Aug 02, 2023

BUY
$508.46 - $591.13 $19,829 - $23,054
39 Added 7.08%
590 $307,000
Q1 2023

May 01, 2023

BUY
$535.0 - $604.82 $16,050 - $18,144
30 Added 5.76%
551 $317,000
Q4 2022

Feb 06, 2023

BUY
$484.71 - $571.37 $27,143 - $31,996
56 Added 12.04%
521 $286,000
Q3 2022

Nov 02, 2022

BUY
$507.19 - $604.49 $7,607 - $9,067
15 Added 3.33%
465 $236,000
Q2 2022

Aug 01, 2022

SELL
$500.9 - $612.21 $12,522 - $15,305
-25 Reduced 5.26%
450 $244,000
Q1 2022

May 10, 2022

BUY
$524.0 - $644.92 $12,576 - $15,478
24 Added 5.32%
475 $281,000
Q4 2021

Feb 02, 2022

SELL
$569.0 - $667.24 $18,208 - $21,351
-32 Reduced 6.63%
451 $301,000
Q3 2021

Nov 09, 2021

BUY
$509.53 - $609.78 $246,102 - $294,523
483 New
483 $276,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Valmark Advisers, Inc. Portfolio

Follow Valmark Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.